SOUTH SAN FRANCISCO, Feb. 5, 2008 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on advancing cancer care, announced today that Steven R. Deitcher, M.D., President & Chief Executive Officer, will present a company update at the 10th Annual BIO CEO & Investor Conference on Tuesday, February 12th at 9:30 a.m. ET in the Beekman Suite at the Waldorf Astoria in New York, NY.
The presentation will be webcast live and archived on the company's website, www.hanabiosciences.com.
About Hana Biosciences, Inc.
Hana Biosciences, Inc. (Nasdaq:HNAB) is a South San Francisco, CA-based biopharmaceutical company focused on acquiring, developing, and commercializing innovative products to advance cancer care. The company is committed to creating value by building a world-class team, accelerating the development of lead product candidates, expanding its pipeline by being the alliance partner of choice, and nurturing a unique company culture. Additional information on Hana Biosciences can be found at www.hanabiosciences.com.
The Hana Biosciences, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3290